Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC009491.1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | AC010287.1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | AC016577.1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
mRNA | AC018867.1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
mRNA | AC023283.1 | CTRPv2 | pan-cancer | AAC | -0.24 | 6e-10 |
mRNA | AC023908.1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | AC090094.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | AC092835.2 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | AC108938.5 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | AC131097.4 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |